US4624849A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antimicrobial lozenges
Assignee: Procter and Gamble Co
•
Filing: 1984-11-02
•
Granted: 1986-11-25
•
Expires: 2004-11-02
Abstract
Abstract Lozenges are disclosed which contain a cationic therapeutic agent effective against plaque and gingivitis and a nonionic lubricant.
Inventors
- 👤 Kevin C. Toogood
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 07:46
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0056; A61K8/00; A61K8/18; A61K8/30; A61K8/40; A61K8/43; A61Q; A61Q11/00
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
77 words
A non-cariogenic lozenge consisting essentially of from about 0.02% to about 1% of a cationic antimicrobial, from about 0.1% to about 4% of a nonionic lubricant selected from the group consisting of polyethylene glycols, hydrogenated tallow, hydrogenated vegetable oil and mixtures thereof and from about 85% to about 99.8% of a filler selected from the group consisting of mannitol, sorbitol, xylitol, polyethylene glycol, non-cariogenic dextrans and mixtures thereof, wherein said lozenge is substantially free of magnesium stearate.
Claim 2
Dependent Claim
77 words
A non-cariogenic lozenge consisting essentially of from about 0.02% to about 1% of a cationic antimicrobial, from about 0.1% to about 4% of a nonionic lubricant selected from the group consisting of polyethylene glycols, hydrogenated tallow, hydrogenated vegetable oil and mixtures thereof and from about 85% to about 99.8% of a filler selected from the group consisting of mannitol, sorbitol, xylitol, polyethylene glycol, non-cariogenic dextrans and mixtures thereof, wherein said lozenge is substantially free of magnesium stearate.
Claim 3
Dependent Claim
25 words
A lozenge according to claim 1 wherein the cationic antimicrobial is selected from the group consisting of quaternary ammonium compounds, substituted guanidines and mixtures thereof.
Claim 4
Dependent Claim
15 words
A lozenge according to claim 2 wherein the cationic antimicrobial agent is a substituted guanidine.
Claim 5
Dependent Claim
16 words
A lozenge according to claim 2 wherein the cationic antimicrobial agent is a quaternary ammonium compound.
Claim 6
Dependent Claim
13 words
A lozenge according to claim 3 wherein the lubricant is hydrogenated vegetable oil.
Claim 7
Dependent Claim
21 words
A lozenge according to claim 5 wherein the filler is selected from the group consisting of sorbitol, mannitol and mixtures thereof.
Claim 8
Dependent Claim
13 words
A lozenge according to claim 6 wherein the cationic antimicrobial agent is chlorhexidine.
Claim 9
Dependent Claim
17 words
A lozenge according to claim 7 which in addition contains a sweetening agent and a flavoring agent.
References Cited (Backward Citations)
US2540253A
Cited
US3096248A
Cited
US3200039A
Cited
US3432592A
Cited
US3271256A
Cited
US3431339A
Cited
US3511914A
Cited
US3439089A
Cited
US3594467A
Cited
US4098879A
Cited
US4169885A
Cited
US4256731A
Cited
EP0026252A1
Cited
US4327076A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-11-24 | 1990-05-26 | 1990-11-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-11-24 | 1994-05-26 | 1994-11-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-11-24 | 1998-05-26 | 1998-11-25 | $7700.00 | Window Closed / Lapsed |